insulin glargine (LY2963016)

insulin glargine · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for insulin glargine (LY2963016), covering 2020-11-24 to 2024-02-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India [Phase 4]